Enfermedades infecciosas y microbiologia clinica (English ed.) · 2025
Rifapentine-based treatment of tuberculosis infection in Spanish adolescents.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Noguera-Julian Antoni, Latre Cristina, Ruiz Montserrat, Garcia-Rebollo Carmen, Peraita Milena, Fortuny Clàudia
Аннотация
INTRODUCTION: Tuberculosis infection (TBI) in adolescents carries a high risk of progression to tuberculosis disease, yet treatment adherence remains a challenge.
METHODS: Case series description.
RESULTS: We describe a real-world experience of implementing a 12-dose weekly regimen of isoniazid (INH) and rifapentine (RPT) under video-observed therapy (VOT) in four adolescent diagnosed with TBI in a contact tracing study. This approach was chosen due to logistical and adherence concerns that made daily regimens and directly observed therapy (DOT) unfeasible. RPT was requested as a foreign medication and approved within three weeks. All patients completed treatment with 100% adherence and good tolerance.
CONCLUSIONS: Our experience supports the feasibility, tolerability, and high adherence of VOT-based weekly INH-RPT regimens in adolescents, despite regulatory barriers limiting RPT access in Europe. Broader availability of RPT and innovative adherence strategies like VOT are urgently needed to optimize TB preventive treatment in this age group. .
METHODS: Case series description.
RESULTS: We describe a real-world experience of implementing a 12-dose weekly regimen of isoniazid (INH) and rifapentine (RPT) under video-observed therapy (VOT) in four adolescent diagnosed with TBI in a contact tracing study. This approach was chosen due to logistical and adherence concerns that made daily regimens and directly observed therapy (DOT) unfeasible. RPT was requested as a foreign medication and approved within three weeks. All patients completed treatment with 100% adherence and good tolerance.
CONCLUSIONS: Our experience supports the feasibility, tolerability, and high adherence of VOT-based weekly INH-RPT regimens in adolescents, despite regulatory barriers limiting RPT access in Europe. Broader availability of RPT and innovative adherence strategies like VOT are urgently needed to optimize TB preventive treatment in this age group. .